EVELUT®: a real-world, observational study assessing dyspnoea and symptom burden in COPD patients switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
mediaposted on 2023-05-31, 12:38 authored by Adis Journals on behalf of:, Roland Buhl, Michael Dreher, Muriel Mattiucci-Guehlke, Rachel Emerson-Stadler, Sebastian Eckhardt, Christian Taube, Claus F. Vogelmeier
Article full text
The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).